Unipharma Co (ROCO:6621) Marketable Securities : NT$100.15 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Unipharma Co Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Unipharma Co's Marketable Securities for the quarter that ended in Dec. 2024 was NT$100.15 Mil.

Unipharma Co's annual Marketable Securities increased from Dec. 2022 (NT$105.50 Mil) to Dec. 2023 (NT$105.54 Mil) but then declined from Dec. 2023 (NT$105.54 Mil) to Dec. 2024 (NT$100.15 Mil).

Unipharma Co Marketable Securities Historical Data

The historical data trend for Unipharma Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Unipharma Co Marketable Securities Chart

Unipharma Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Marketable Securities

Get a 7-Day Free Trial

113.50

99.50

105.50

105.54

100.15

Unipharma Co Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Marketable Securities	Get a 7-Day Free Trial															105.50	105.52	105.54	105.56	100.15

Unipharma Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Unipharma Co (ROCO:6621) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Unipharma Co Marketable Securities Related Terms

Thank you for viewing the detailed overview of Unipharma Co's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Unipharma Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Unipharma Co Ltd (ROCO:6621) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jiu Zong Road, 3rd Floor, No. 17, Lane 171, Section 2, NeiHu District, Taipei, TWN, 11494

Website

http://www.uni-pharma.com

Unipharma Co Ltd is a medical diagnostic, pharmaceutical and medical device company. It is engaged in developing drug products and medical equipment. The company's products offerings include Baxter, Tambocor tablets, Bain Injection, Esmolol HCL Injection, Naloxone Injection, and SAM Pelvic Sling medical device. Its customers are major medical centers, regional hospitals, regional hospitals, and clinics.

Unipharma Co Headlines

No Headlines